Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 J&J To Buy Japanese Skin Care Firm - Happi
Company News

J&J To Buy Japanese Skin Care Firm

Will buy holding company that owns Dr.Ci:Labo and Labo Labo brands.

Johnson & Johnson says it has reached a deal with Ci:z Holdings Co., Ltd., the Japanese company behind Dr.Ci:Labo, Labo Labo and Genomer skin care brands, to launch an all-cash offer to acquire all of the outstanding shares of the company not already held by Johnson & Johnson and its affiliates for approximately ¥230 billion.

“Health and beauty consumers are actively seeking science-based innovation to improve their skin,” said Jorge Mesquita, worldwide chairman, Johnson & Johnson Consumer. “This transaction will maximize value creation for Johnson & Johnson's Consumer business by bringing in an agile innovation model and rapidly accelerating sales through our global commercialization expertise.”

In July 2016, Cilag GmbH International, an affiliate of J&J, entered into a long-term strategic collaboration with the company, to distribute the company's brands outside of Japan. As part of this collaboration, Cilag acquired approximately 19.9% of the outstanding shares of the company.

The tender offer is part of a series of transactions pursuant to which Johnson & Johnson intends to acquire all the outstanding shares of the company, including a separate transaction whereby Johnson & Johnson will acquire the shares of the company held by CIC Corporation, the ownership vehicle of the company's founder, Dr. Yoshinori Shirono. 

J&J said thetransaction will be a “springboard to build Johnson & Johnson Consumer's connected commerce capabilities by leveraging one of the largest customer relationship management databases for direct-to-consumer skincare in Japan.” 

The deal will also provide the opportunity to expand and improve retail presence through Johnson & Johnson's Consumer capabilities and well-established distribution networks.

The tender offer is expected to close in the first quarter of 2019. 

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters